Comparative Analysis of the Human Proteome Profile in Visceral Adipose and Liver Tissue in Individuals with Obesity with and Without MASLD and MASH
Background/Objectives: Visceral adipose tissue (VAT) may play a direct role in the development of metabolic dysfunction-associated steatotic liver disease (MASLD) and its progression to metabolic dysfunction-associated steatohepatitis (MASH). In this study, we employed untargeted proteomics analyses...
Saved in:
Main Authors: | Julie S. Pedersen, Lili Niu, Nicolai J. Wewer Albrechtsen, Viggo B. Kristiansen, Inge Marie Poulsen, Reza R. Serizawa, Torben Hansen, Lise Lotte Gluud, Sten Madsbad, Flemming Bendtsen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-04-01
|
Series: | Livers |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-4389/5/2/16 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
C/EBPβ–VCAM1 axis in Kupffer cells promotes hepatic inflammation in MASLD
by: Shuang-Zhe Lin, et al.
Published: (2025-08-01) -
Effect of Pemafibrate, a Selective Peroxisome Proliferator-activated Receptor ? Modulator (SPPARM?), on the Lipid Profile, Liver Function, and Liver Fibrosis among Patients with Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
by: Mona Hassan, et al.
Published: (2025-06-01) -
Development of a Vertical Mashing Machine and Specifying its Main Parameters
by: A. V. Bogdanov, et al.
Published: (2023-04-01) -
Resolvin D1-mediated cellular crosstalk protects against MASH
by: Amaia Navarro-Corcuera, et al.
Published: (2025-08-01) -
Correction: An engineered adipose formulation decreases hepatic inflammation and fibrosis in a rodent model of metabolic dysfunction-associated steatotic liver disease
by: Youngshim Choi, et al.
Published: (2025-06-01)